Potent estrogen agonists based on carborane as a hydrophobic skeletal structure - A new medicinal application of boron clusters

被引:172
作者
Endo, Y
Iijima, T
Yamakoshi, Y
Fukasawa, H
Miyaura, C
Inada, M
Kubo, A
Itai, A
机构
[1] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan
[2] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo 1920392, Japan
[3] Key Mol Inc, Inst Med Mol Design, Bunkyo Ku, Tokyo 1130033, Japan
来源
CHEMISTRY & BIOLOGY | 2001年 / 8卷 / 04期
关键词
carborane; estrogen ligand; hydrophobic interaction; nuclear receptor;
D O I
10.1016/S1074-5521(01)00016-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Carboranes (dicarba-closo-dodecaboranes) are a class of carbon-containing polyhedral boron-cluster compounds having remarkable thermal stability and exceptional hydrophobicity. Applications of the unique structural and chemical properties offered by icosahedral carboranes in boron neutron capture therapy have received increasing attention over the past 30 years. However, these features of carboranes may allow another application as a hydrophobic pharmacophore in biologically active molecules that interact hydrophobically with receptors. Results: We have designed candidate estrogen-receptor-binding compounds having carborane as a hydrophobic skeletal structure and synthesized them. The most potent compound bearing a carborane cage exhibited activity at least 10-fold greater than that of 17 beta -estradiol in the luciferase reporter gene assay. Estrogen receptor-alpha -binding data for the compound were consistent with the results of the luciferase reporter gene assay. The compound also showed potent in vivo effects on the recovery of uterine weight and bone loss in ovariectomized mice. Conclusion: Further development of the potent carborane-containing estrogenic agonists described here, having a new skeletal structure and unique characteristics, should yield novel therapeutic agents, especially selective estrogen receptor modulators. Furthermore, the suitability of the spherical carborane cage for binding to the cavity of the estrogen receptor-alpha ligand-binding domain should provide a basis for a similar approach to developing novel ligands for other steroid receptors. (C) 2001 Elsevier science Ltd. All rights reserved.
引用
收藏
页码:341 / 355
页数:15
相关论文
共 37 条
[1]   DICARBA-CLOSO-DODECABORANES C2B10H12 AND THEIR DERIVATIVES [J].
BREGADZE, VI .
CHEMICAL REVIEWS, 1992, 92 (02) :209-223
[2]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[3]  
CASE DA, 1997, AMBER 5
[4]   C-ARYLATION AND C-HETEROARYLATION OF ICOSAHEDRAL CARBORANES VIA THEIR COPPER(I) DERIVATIVES [J].
COULT, R ;
FOX, MA ;
GILL, WR ;
HERBERTSON, PL ;
MACBRIDE, JAH ;
WADE, K .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1993, 462 (1-2) :19-29
[5]   OE strogenic activity of alkylated stilb oe strols [J].
Dodds, EC ;
Golberg, L ;
Lawson, W ;
Robinson, R .
NATURE, 1938, 142 :34-34
[6]   HORMONE-RECEPTOR INTERACTIONS - [4-CARBORANYLALANINE, 5-LEUCINE]-ENKEPHALIN AS A STRUCTURAL PROBE FOR OPIATE RECEPTOR [J].
EBERLE, A ;
LEUKART, O ;
SCHILLER, P ;
FAUCHERE, J ;
SCHWYZER, R .
FEBS LETTERS, 1977, 82 (02) :325-328
[7]   Polymethylcarborane as a novel bioactive moiety: Derivatives with potent retinoid antagonistic activity [J].
Endo, Y ;
Yaguchi, K ;
Kawachi, E ;
Kagechika, H .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (15) :1733-1736
[8]   Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cδ by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation [J].
Endo, Y ;
Takehana, S ;
Ohno, M ;
Driedger, PE ;
Stabel, S ;
Mizutani, MY ;
Tomioka, N ;
Itai, A ;
Shudo, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (09) :1476-1496
[9]   Protein kinase C modulators bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore [J].
Endo, Y ;
Yoshimi, T ;
Kimura, K ;
Itai, A .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) :2561-2564
[10]   Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore [J].
Endo, Y ;
Iijima, T ;
Yamakoshi, Y ;
Yamaguchi, M ;
Fukasawa, H ;
Shudo, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1501-1504